Saturday, October 3, 2026

USD/CNH Over 1% Down In The Last 10 Sessions

ViaNews Editorial Team

February 28, 2024

USD/CNH Over 1% Down In The Last 10 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 1.53% for the last 10 sessions. At 06:08 EST on Wednesday, 28 February, USD/CNH (USDCNH) is $7.22.

USD/CNH's yearly highs and lows, it's 0.086% up from its 52-week low and 0.042% down from its 52-week high.

News about

  • Eur/usd signal: bearish amid potential fed and ECB divergence - 26 February 2024. According to DailyForex on Monday, 26 February, "The EUR/USD exchange rate rose to the two-week high of 1.0888 and then quickly pulled back as traders continued to reflect on the Federal Reserve minutes. ", "The EUR/USD pair formed an inverse hanging man pattern last week after the latest FOMC minutes. "
  • Eur/usd: A break below 1.0700 could swiftly shift market focus towards the 1.0500 target – HSBC. According to FXStreet on Monday, 26 February, "Economists at HSBC analyze how the ECB's upcoming March meeting could impact the EUR/USD and EUR/GBP.", "In the EUR/USD pair, the 1.0700 level serves as crucial support, with potential upward movement capped at 1.0930 in the absence of significant ECB language changes. "
  • Eur/usd gains as market participans await inflation and growth data. According to FXStreet on Monday, 26 February, "New Home Sales rose by 1.5% from 0.651M to 0.661M, less than expected, and witnessed a muted reaction in the EUR/USD pair.", "Meanwhile, the EUR/USD could witness some weakness, as an article by Bloomberg suggested that investors are cutting their Euro longs to their lowest level since November 2022 via the Commodities and Futures Trading Commission (CFTC) data."
  • Eur/usd to move towards 1.0500 on a three-month – rabobank. According to FXStreet on Monday, 26 February, "Economists at Rabobank expect the US Dollar (USD) to remain resilient over the next weeks and forecast EUR/USD at 1.0500 in three months.", "We continue to see the potential for EUR/USD to move towards 1.0500 on a three-month view before edging higher into year-end."

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com